Last updated on August 2016

A Prospective, Phase 2a Study to Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts) in Subjects Ages 18-65 Years


Brief description of study

A Prospective, Phase 2a Study to Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts) in Subjects Ages 18-65 Years

Detailed Study Description

This study is looking at the effectiveness of an investigational drug in the treatment of common warts. This includes warts on the hands and feet but NOT genital warts. Either one cluster of warts less than 80mm in diameter or up to 4 individual warts between 3mm and 20mm in diameter may be treated. Patients must be in good health, ages 18-65 years. Patients must be available for weekly appointments. The study lasts 3-6 months. Criteria for entry apply.

Clinical Study Identifier: TX144859

Find a site near you

Start Over

Mount Sinai St. Luke's

1090 Amsterdam Avenue, 11th Floor New York, NY USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.